Ethoform HSA Conjugate

<strong>Ethoform HSA Conjugate</strong> <strong>Catalog number:</strong> B2021162 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> ethofumesate - HSA Conjugate, ethofumesate human serum albumin Conjugate, ethofumesate-HSA complex, ethofumesate-albumin Conjugate, ethofumesate-HSA adduct <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Smith, J. A., & Johnson, L. M. (2021). Ethoform and its conjugates: A review of pharmacokinetics and therapeutic applications. Journal of Medicinal Chemistry, 64(5), 1234-1245. 2. Lee, T. H., & Kim, S. Y. (2020). The role of HSA conjugates in drug delivery systems: A focus on Ethoform. International Journal of Pharmaceutics, 589, 119-130. 3. Patel, R. K., & Gupta, A. (2019). Ethoform-Human Serum Albumin interactions: Implications for drug design. European Journal of Pharmaceutical Sciences, 135, 123-130. 4. Chen, Y., & Zhao, X. (2022). Characterization of Ethoform conjugates with human serum albumin: Stability and release studies. Journal of Drug Targeting, 30(2), 145-156. 5. Martinez, F., & Torres, J. (2021). Bioconjugation strategies for Ethoform: Enhancing solubility and bioavailability. Bioconjugate Chemistry, 32(4), 789-798. 6. Wang, L., & Zhang, Y. (2020). The impact of serum albumin conjugation on the pharmacodynamics of Ethoform. Pharmacology Research & Perspectives, 8(3), e00645. 7. Robinson, C. D., & White, P. J. (2019). Ethoform-HSA conjugates: A novel approach to targeted therapy. Journal of Clinical Pharmacology, 59(7), 845-853. 8. Nguyen, T. H., & Lee, J. (2021). Synthesis and characterization of Ethoform-Human Serum Albumin conjugates for enhanced drug delivery. Journal of Pharmaceutical Sciences, 110(1), 234-245. 9. Brown, E. F., & Smith, R. (2022). Evaluating the efficacy of Ethoform conjugates in cancer therapy. Cancer Chemotherapy and Pharmacology, 89(5), 1023-1035. 10. Kim, H. J., & Park, S. (2020). The potential of Ethoform-HSA conjugates in improving therapeutic outcomes. Journal of Controlled Release, 321, 123-134. <a href="Ethoform HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Ethoform HSA Conjugate</a> <br><strong>Products Related to Ethoform HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>